KR920014474A - 담석 붕괴용 제제 - Google Patents

담석 붕괴용 제제 Download PDF

Info

Publication number
KR920014474A
KR920014474A KR1019920000806A KR920000806A KR920014474A KR 920014474 A KR920014474 A KR 920014474A KR 1019920000806 A KR1019920000806 A KR 1019920000806A KR 920000806 A KR920000806 A KR 920000806A KR 920014474 A KR920014474 A KR 920014474A
Authority
KR
South Korea
Prior art keywords
aqueous solution
alkali metal
formulation according
metal carbonate
acetylcysteine
Prior art date
Application number
KR1019920000806A
Other languages
English (en)
Inventor
모리야스 아끼히또
Original Assignee
요시다 쇼오지
센쥬세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 요시다 쇼오지, 센쥬세이야꾸 가부시끼가이샤 filed Critical 요시다 쇼오지
Publication of KR920014474A publication Critical patent/KR920014474A/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Lubricants (AREA)

Abstract

내용 없음

Description

담석 붕괴용 제제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (9)

  1. 알칼리금속 카르보네이트 또는 알칼리금속 카르보네이트와 N-아세틸시스테인의 조합을 함유한 수용액을 포함하는 담석 붕괴용 제제.
  2. 제1항에 있어서, 알칼리금속 카르보네이트가 탄산수소화나트륨, 탄산수소화칼륨, 탄산나트륨 또는 탄산칼륨제인 제제.
  3. 제1항에 있어서, 알칼리금속 카르보네이트를 수용액중 1∼30%(w/v)의 양으로 함유하는 제제.
  4. 제3항에 있어서, 알칼리금속 카르보네이트를 수용액중 5∼20%(w/v)의 양으로 함유하는 제제.
  5. 제1항에 있어서, N-아세틸시스테인이 수용액중 5∼30%(w/v)의 양으로 함유하는 제제.
  6. 제5항에 있어서, N-아세틸시스테인이 수용액중 10∼25%(w/v)의 양으로 함유하는 제제.
  7. 제1항에 있어서, 수용액의 pH가 7∼10의 범위인 제제.
  8. 제1항에 있어서, 수용액의 매질이 증류수인 제제.
  9. 담석 보유 환자에게, 알칼리금속 카르보네이트 또는 알칼리금속 카르보네이트와 N-아세틸시스테인의 조합을 함유한 수용액을 포함하는 담석 붕괴용 제제의 유효량을 투여하는 것으로 이루어진 담석증 치료방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920000806A 1991-01-26 1992-01-21 담석 붕괴용 제제 KR920014474A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP91-25596 1991-01-26
JP2559691 1991-01-26

Publications (1)

Publication Number Publication Date
KR920014474A true KR920014474A (ko) 1992-08-25

Family

ID=12170291

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920000806A KR920014474A (ko) 1991-01-26 1992-01-21 담석 붕괴용 제제

Country Status (10)

Country Link
US (1) US5441748A (ko)
EP (1) EP0497724B1 (ko)
JP (1) JPH0558900A (ko)
KR (1) KR920014474A (ko)
AT (1) ATE135915T1 (ko)
CA (1) CA2059977A1 (ko)
DE (1) DE69209335T2 (ko)
DK (1) DK0497724T3 (ko)
ES (1) ES2084971T3 (ko)
GR (1) GR3020175T3 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593688A (en) * 1993-06-25 1997-01-14 Nexstar Pharmaceuticals, Inc. Liposomal targeting of ischemic tissue
AU7024094A (en) * 1993-08-16 1995-02-23 Senju Pharmaceutical Co., Ltd. A bile duct deterging composition and a method for deterging the bile duct
WO2002030432A1 (en) * 2000-06-23 2002-04-18 Cambridgemed, Inc Agent for reduction of scar formation by using wound alkalinization
US20050142208A1 (en) 2002-05-09 2005-06-30 Won Min Yoo Pharmceutical composition for treatment of wounds conntaining blood plasma or serum
US8148356B2 (en) 2005-08-24 2012-04-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
US9615601B2 (en) 2005-10-04 2017-04-11 Jimmyash Llc Process for the controlled introduction of oil into food products
ES2603406T3 (es) 2005-10-04 2017-02-27 Jimmyash Llc Procedimientos de producción de productos alimenticios de aperitivo y productos así preparados
EP1933648B1 (en) 2005-10-04 2018-03-28 JimmyAsh LLC Fried food products having reduced fat content

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451454A (en) * 1981-06-16 1984-05-29 Wong Dennis W Prophylaxis and treatment of thromboembolic disorders in man and in warm-blooded animals with bicarbonate salts of alkali metals
DE3173007D1 (en) * 1981-09-14 1986-01-02 Olima Holding Ag Pharmaceutical oral dosage forms of an active agent capable of forming or releasing bicarbonate ions
DD268864A1 (de) * 1985-09-02 1989-06-14 Karl Marx Uni Buero Fuer Neuer Verfahren zur herstellung von mitteln fuer parenterale ernaehrung
CH667590A5 (it) * 1986-07-24 1988-10-31 Inpharzam Int Sa Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. .
DE3739401A1 (de) * 1987-11-20 1989-06-01 U Prof Dr Med Leuschner Pharmazeutische zubereitung zur cholelitholyse (aufloesung von gallensteinen)

Also Published As

Publication number Publication date
EP0497724B1 (en) 1996-03-27
DK0497724T3 (da) 1996-04-29
DE69209335T2 (de) 1996-08-29
ATE135915T1 (de) 1996-04-15
DE69209335D1 (de) 1996-05-02
CA2059977A1 (en) 1992-07-27
ES2084971T3 (es) 1996-05-16
GR3020175T3 (en) 1996-09-30
US5441748A (en) 1995-08-15
EP0497724A1 (en) 1992-08-05
JPH0558900A (ja) 1993-03-09

Similar Documents

Publication Publication Date Title
ES2089954B1 (es) Metodo para preparar una emulsion de hidrocarburo viscoso en solucion tampon acuosa.
KR920014465A (ko) 입욕제
KR920009405A (ko) 살균 조성물
AR010579A1 (es) Composicion de limpieza y desinfeccion acuosa lista para usar y proceso para desinfeccion de superficies duras.
DE3577397D1 (de) Fluessige diclofenac-zubereitungen.
ES527150A0 (es) Un procedimiento para la preparacion de una solucion desinfectante acuosa de peroxido de hidrogeno.
BRPI9906372B8 (pt) composição farmaceutica aquosa para aplicação na mucosa
ES2109779T3 (es) Emulsion que contiene acido ascorbico estabilizado.
ES2022883B3 (es) Una composicion desodorante y uso de ella
AR004168A1 (es) Composicion farmaceutica liquida vertible acuosa
NZ505821A (en) Pharmaceutical compositions of uridine triphosphate
KR920014474A (ko) 담석 붕괴용 제제
ES2145302T3 (es) Agente de blanqueo.
JPS6434909A (en) Cosmetic
AR000504A1 (es) Procedimiento para la producción de una solución acuosa biocida de acción prolongada basada en ionesperacéticos
ES2161235T3 (es) Una composicion de glutaraldehido.
ES2149037T3 (es) Emulsion que contiene acido ascorbico y sus utilizaciones en los ambitos cosmetico y dermatologico.
PE33396A1 (es) Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar
KR930019808A (ko) 세정제 조성물
AR015917A1 (es) Composiciones de materia que contiene sertralina y procedimiento para aumentar su solubilidad en un medio acuoso
ES2092559T3 (es) Formulacion farmaceutica que contiene penciclovir.
MX9302924A (es) Agente para tratamiento de cataratas y metodo para su preparacion.
ES2070806B1 (es) Jarabe que contiene n-acetil-cisteina.
ES2196814T3 (es) Preparacion desinfectante que contiene cloro en alcohol.
ES2152235T3 (es) Solucion esclerosante.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application